Longeveron, Inc. (LGVN)
Longeveron Market Cap: 10.62M for Dec. 31, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| CEL-SCI Corp. | 15.78M |
| AIM ImmunoTech, Inc. | 0.8483M |
| IGC Pharma, Inc. | 25.85M |
| NovaBay Pharmaceuticals, Inc. | 711.96M |
| Protalix Biotherapeutics, Inc. | 144.36M |
Market Cap Related Metrics
| PS Ratio | 5.474 |
| Price to Book Value | 1.065 |
| Price | 0.4976 |
| Earnings Yield | -268.7% |